设计一种新的HSV-1菌株,用于固体瘤的瘤治疗
Karina Vázquez-Arreguín1, Alex Gonzalez2, Amy Webb3
1Department of Pathology, Georgia Cancer Center at Augusta University, Augusta, GA 30912, USA.
Molecular therapy. Oncology
|April 1, 2025
概括
一种新的瘤性简单疹病毒 (HSV) - 1菌株,OncoDelta (OncoD),被设计用于癌症治疗. 这种修改后的病毒显示了瘤特异性杀死,在小鼠中安全,并增强了抗瘤免疫力,与辐射协同作用.
科学领域:
- 病毒学 病毒学
- 瘤学病毒治疗疗法 瘤学病毒治疗
- 癌症研究 癌症研究
背景情况:
- 瘤性简单疹病毒 (HSV) -1 是癌症治疗的有希望的候选人.
- 工程HSV-1旨在提高其作为治疗剂的安全性和有效性.
研究的目的:
- 隔离和设计一种新的HSV-1菌株,用于安全有效的瘤性病毒疗法.
- 描述工程病毒的安全性,有效性和免疫激活潜力.
主要方法:
- 从患者样本中分离出一种新的HSV-1菌株 (UT1a).
- 在CRISPR-Cas9中介的工程中,删除病毒基因 (UL39,UL40,RL1) 创建OncoDelta (OncoD).
- 在小鼠模型中进行了体外和体外研究,以评估安全性,瘤细胞细胞毒性,复制和抗瘤免疫反应.
主要成果:
- 在OncoD中显示出瘤细胞特异性细胞毒性和复制性.
- 在小鼠的内注射表明OncoD在最大剂量时是安全的和无毒的.
- 在多种瘤模型中,OncoD表现出显著的抗瘤免疫激活潜力.
- 转录基因组分析显示,OncoD会损害DNA损伤的修复,从而与体外和体内辐射疗法产生协同作用.
结论:
- 改造后的OncoDelta (OncoD) 病毒是一种安全而强大的瘤解毒剂,具有瘤特异性活性.
- OncoD具有显著的抗瘤免疫激活特性,并与放射治疗协同作用,改善癌症治疗结果.
相关概念视频
01:28Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...